Clinical trial
Spironolactone Versus Indapamide in Obese and Hypertensive Patients
NCT03626506
Study timeline
Study start (actual)2019-02-13Date precision: day
Registry last updated2019-12-03
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Hypertensionunresolved
Interventions
SpironolactoneDRUG · verified · RxNorm: spironolactone
IndapamideDRUG · verified · RxNorm: indapamide
AmlodipineDRUG · verified · RxNorm: amlodipine
Sponsors & collaborators
Peking University Third Hospitallead sponsor
University of Michigancollaborator
Peking Universitycollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03626506 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.